There are 2789 resources available
843P - Characteristics and outcomes of ocular adnexal lymphomas: Experience of a tertiary cancer care center over 16 years
Presenter: Inês Oliveira
Session: ePoster Display
772P - Hormonal therapy in pretreated patients with metastatic or refractory ovary granulosa cell tumor
Presenter: Izzet Dogan
Session: ePoster Display
773P - Prognostic value of preoperative soluble interleukin 2 receptor α as a novel immune biomarker in epithelial ovarian cancer
Presenter: Hui Li
Session: ePoster Display
774P - Anlotinib plus sintilimab in patients with recurrent advanced cervical cancer: A prospective, multicenter, single-arm, phase II clinical trial
Presenter: Qin Xu
Session: ePoster Display
924P - HANNA: Effectiveness and quality-of-life data from a real-world study of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN) treated with nivolumab in Germany
Presenter: Harald Müller-Huesmann
Session: ePoster Display
676P - CABOPRE: A phase II study of cabozantinib (cabo) prior cytoreductive nephrectomy (CN) in metastatic renal cell carcinoma (mRCC)
Presenter: Guillermo De Velasco
Session: ePoster Display
749P - Cardiotoxicity in patients treated with PARP-inhibitors
Presenter: Mariola Blanco Clemente
Session: ePoster Display
678P - Cytoreductive nephrectomy (CN) for patients with metastatic sarcomatoid and/or rhabdoid (S/R) renal cell carcinoma (RCC) treated with immune checkpoint inhibitors (ICI)
Presenter: Andrew Hahn
Session: ePoster Display
680P - Cabozantinib and axitinib after VEGF therapy in patients with aRCC: A retrospective cohort study
Presenter: Janet Brown
Session: ePoster Display